Recall D-0028-2026

US Class II Ongoing · initiated 2025-10-08

Recalling firm

ASTRAZENECA PHARMACEUTICALS, MD

Product

Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30

Reason for recall

Lack of Assurance of Sterility:

← All recalls